Emcure Pharmaceuticals Faces Regulatory Scrutiny Following US FDA Inspection at Sanand Facility
Emcure Pharmaceuticals Ltd, a prominent Indian pharmaceutical company, received seven observations from the United States Food and Drug Administration (US FDA) following an inspection of its formulations manufacturing facility in Sanand, Gujarat, which concluded this week. Despite the regulatory development, the company’s stock demonstrated resilience on the Bombay Stock Exchange (BSE), closing at ₹1,702.30 on…
